These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10407938)

  • 1. [Tablets in stool? A common problem!].
    Schuerch LV; Nyfeler J; Holder G; Surber C; Haefeli WE
    Schweiz Med Wochenschr; 1999 May; 129(17):670-3. PubMed ID: 10407938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro dissolution of oral modified-release tablets and capsules in ethanolic media.
    Smith AP; Moore TW; Westenberger BJ; Doub WH
    Int J Pharm; 2010 Oct; 398(1-2):93-6. PubMed ID: 20667505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A flexible technology for modified release of drugs: multi layered tablets.
    Abdul S; Poddar SS
    J Control Release; 2004 Jul; 97(3):393-405. PubMed ID: 15212872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ghost-Pill-Buster: A Case Study of Intact Levetiracetam Extended-Release Tablets after Dissolution Testing.
    Sun D; Wen H; Externbrink A; Gao Z; Keire D; Krauss G; Jiang W
    CNS Drugs; 2016 May; 30(5):455-60. PubMed ID: 27048352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid oral dosage forms.
    Helliwell M; Taylor D
    Prof Nurse; 1993 Feb; 8(5):313-7. PubMed ID: 8451252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of dissolution induced changes in film coat composition by 1H NMR spectroscopy and SEM.
    Strübing S; Metz H; Syrowatka F; Mäder K
    J Control Release; 2007 Jun; 119(2):190-6. PubMed ID: 17434640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug formulation and biologic availability.
    Poole JW
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of gastric banding on pharmacotherapy: not much known].
    Wilting I; van den Bemt PM; Brenninkmeijer SJ; Spooren PF; Siemons AA; Egberts AC
    Ned Tijdschr Geneeskd; 2007 May; 151(20):1112-5. PubMed ID: 17557666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis.
    Safdi M; Bekal PK; Martin S; Saeed ZA; Burton F; Toskes PP
    Pancreas; 2006 Aug; 33(2):156-62. PubMed ID: 16868481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral controlled release preparations.
    García CR; Siqueiros A; Benet LZ
    Pharm Acta Helv; 1978; 53(3-4):99-109. PubMed ID: 360228
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel compression-coated doughnut-shaped tablet design for zero-order sustained release.
    Sundy E; Danckwerts MP
    Eur J Pharm Sci; 2004 Aug; 22(5):477-85. PubMed ID: 15265518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of amoxicillin intragastric buoyant sustained-release tablets and the dissolution characteristics.
    Tokumura T; Machida Y
    J Control Release; 2006 Feb; 110(3):581-6. PubMed ID: 16380190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of enteric capsules by means of hot-melt extrusion.
    Mehuys E; Remon JP; Vervaet C
    Eur J Pharm Sci; 2005 Feb; 24(2-3):207-12. PubMed ID: 15661492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic inequivalence of pharmaceutical alternates.
    Levy RA
    Am Pharm; 1985 Apr; NS25(4):28-39. PubMed ID: 3893084
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs].
    Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS
    Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained-release methylphenidate: new preparations. New pharmaceutical forms: a slight advantage for a small number of children.
    Prescrire Int; 2004 Dec; 13(74):203-6. PubMed ID: 15612099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of various factors on the velocity of drug release from depot tablets. 2. Isoniazid-depot tablets].
    Naplatanova D; Tomassini L
    Pharmazie; 1974 May; 29(5):321-3. PubMed ID: 4848951
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of controlled-release on the pharmacokinetics and absorption characteristics of a compound undergoing intestinal efflux in humans.
    Tubic M; Wagner D; Spahn-Langguth H; Weiler C; Wanitschke R; Böcher WO; Langguth P
    Eur J Pharm Sci; 2006 Nov; 29(3-4):231-9. PubMed ID: 16713700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and evaluation of floating multi-layer coated tablets based on gas formation.
    Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.